Interferon-γ 	Interferon-γ 	 NNP	B-NP
/ 	/ 	 NNP	O
CCR5  	CCR5  	 NNP	B-NP
expression  	expression  	 NN	I-NP
in  	in  	 IN	O
invariant  	invariant  	 JJ	O
natural  	natural  	 JJ	O
killer  	killer  	 NN	B-NP
T  	T  	 NN	I-NP
cells  	cells  	 NNS	I-NP
and  	and  	 CC	O
CCL5  	CCL5  	 CD	B-NP
expression  	expression  	 NN	I-NP
in  	in  	 IN	O
capillary  	capillary  	 JJ	B-NP
veins  	veins  	 NN	I-NP
of  	of  	 IN	I-NP
dermal  	dermal  	 JJ	I-NP
papillae  	papillae  	 JJ	I-NP
correlate  	correlate  	 NN	O
with  	with  	 IN	O
development  	development  	 NN	O
of  	of  	 IN	O
psoriasis  	psoriasis  	 NNS	B-NP
vulgaris  	vulgaris  	 VBP	O
There  	There  	 EX	O
have  	have  	 VBP	O
been  	been  	 VBN	O
extensive  	extensive  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
regarding  	regarding  	 VBG	O
which  	which  	 WDT	O
types  	types  	 NNS	O
of  	of  	 IN	O
T  	T  	 NN	B-NP
lymphocytes  	lymphocytes  	 NNS	I-NP
are  	are  	 VBP	O
involved  	involved  	 VBN	O
in  	in  	 IN	O
psoriasis  	psoriasis  	 JJ	B-NP
vulgaris  	vulgaris  	 NNS	I-NP
( 	( 	 -LRB-	O
PV 	PV 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
it  	it  	 PRP	O
has  	has  	 VBZ	O
remained  	remained  	 VBN	O
unclear  	unclear  	 NNS	O
which  	which  	 WDT	O
types  	types  	 NNS	O
of  	of  	 IN	O
T  	T  	 NN	B-NP
lymphocytes  	lymphocytes  	 NNS	I-NP
might  	might  	 MD	O
directly  	directly  	 RB	O
contribute  	contribute  	 VB	O
to  	to  	 TO	O
psoriasiform  	psoriasiform  	 VB	O
epidermal  	epidermal  	 NNS	B-NP
and  	and  	 CC	O
vascular  	vascular  	 JJ	B-NP
hyperplasia 	hyperplasia 	 NN	I-NP
.  	.  	 .	O
To  	To  	 TO	O
understand  	understand  	 VB	O
the  	the  	 DT	O
role  	role  	 NN	O
of  	of  	 IN	O
T-cell  	T-cell  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
( 	( 	 -LRB-	O
TCR 	TCR 	 NNP	B-NP
) 	) 	 -RRB-	O
Vα24+  	Vα24+  	 FW	O
invariant  	invariant  	 FW	B-NP
natural  	natural  	 FW	I-NP
killer  	killer  	 FW	I-NP
( 	( 	 -LRB-	O
iNK 	iNK 	 NNP	B-NP
) 	) 	 -RRB-	O
T  	T  	 NN	O
cells  	cells  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
development  	development  	 NN	O
of  	of  	 IN	O
PV 	PV 	 NNP	B-NP
.  	.  	 .	O
Seventeen  	Seventeen  	 JJ	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
enrolled  	enrolled  	 VBN	O
in  	in  	 IN	O
this  	this  	 DT	O
study 	study 	 NN	O
.  	.  	 .	O
Using  	Using  	 VBG	O
biopsy  	biopsy  	 JJ	B-NP
samples  	samples  	 NNS	I-NP
of  	of  	 IN	I-NP
PV  	PV  	 NNP	I-NP
plaques 	plaques 	 NN	I-NP
,  	,  	 ,	O
TCRVα24 	TCRVα24 	 NNP	B-NP
( 	( 	 -LRB-	I-NP
+ 	+ 	 NNP	I-NP
)  	)  	 -RRB-	I-NP
iNKT  	iNKT  	 JJ	I-NP
cells  	cells  	 NNS	I-NP
were  	were  	 VBD	O
investigated  	investigated  	 VBN	O
regarding  	regarding  	 VBG	O
their  	their  	 PRP$	O
cytokine  	cytokine  	 JJ	B-NP
production  	production  	 NN	I-NP
to  	to  	 TO	O
understand  	understand  	 VB	O
their  	their  	 PRP$	O
roles  	roles  	 NNS	O
in  	in  	 IN	O
development  	development  	 NN	O
of  	of  	 IN	O
disease 	disease 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
interferon  	interferon  	 NNS	B-NP
( 	( 	 -LRB-	O
IFN 	IFN 	 NNP	B-NP
) 	) 	 -RRB-	O
-γ+  	-γ+  	 CD	O
iNKT  	iNKT  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
correlated  	correlated  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
length  	length  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
psoriasiform  	psoriasiform  	 FW	B-NP
hyperplasia  	hyperplasia  	 FW	I-NP
rete  	rete  	 FW	I-NP
ridge  	ridge  	 FW	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
Psoriasis  	Psoriasis  	 NNP	B-NP
Area  	Area  	 NNP	I-NP
and  	and  	 CC	O
Severity  	Severity  	 NNP	B-NP
Index 	Index 	 NNP	I-NP
.  	.  	 .	O
IFN-γ+  	IFN-γ+  	 NNP	B-NP
iNKT  	iNKT  	 JJ	O
cells  	cells  	 NNS	O
in  	in  	 IN	O
psoriatic  	psoriatic  	 JJ	B-NP
skin  	skin  	 NN	I-NP
exhibited  	exhibited  	 NN	I-NP
higher  	higher  	 RBR	O
C-C  	C-C  	 JJ	B-NP
chemokine  	chemokine  	 JJ	I-NP
receptor  	receptor  	 NN	I-NP
( 	( 	 -LRB-	O
CCR 	CCR 	 NNP	B-NP
) 	) 	 -RRB-	O
5  	5  	 CD	O
expression 	expression 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
C-C  	C-C  	 JJ	B-NP
chemokine  	chemokine  	 JJ	I-NP
ligand  	ligand  	 NNS	I-NP
( 	( 	 -LRB-	O
CCL 	CCL 	 NNP	B-NP
) 	) 	 -RRB-	I-NP
5 	5 	 CD	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
ligand  	ligand  	 NN	B-NP
for  	for  	 IN	I-NP
CCR5 	CCR5 	 NNP	I-NP
,  	,  	 ,	O
was  	was  	 VBD	O
increased  	increased  	 VBN	O
in  	in  	 IN	O
capillary  	capillary  	 JJ	B-NP
veins  	veins  	 NN	I-NP
of  	of  	 IN	I-NP
psoriasis  	psoriasis  	 JJ	I-NP
plaques 	plaques 	 NN	I-NP
.  	.  	 .	O
CCR5+  	CCR5+  	 NNP	B-NP
iNKT-cell  	iNKT-cell  	 JJ	O
numbers  	numbers  	 NNS	O
significantly  	significantly  	 RB	O
correlated  	correlated  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
capillary  	capillary  	 FW	B-NP
vein  	vein  	 FW	I-NP
endothelial  	endothelial  	 FW	I-NP
cells  	cells  	 FW	I-NP
expressing  	expressing  	 FW	I-NP
CCL5  	CCL5  	 FW	I-NP
in  	in  	 FW	O
PV 	PV 	 FW	B-NP
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
CCL5+  	CCL5+  	 CD	B-NP
capillary  	capillary  	 NNS	O
veins  	veins  	 VBP	O
correlated  	correlated  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
maximum  	maximum  	 JJ	O
rete  	rete  	 JJ	B-NP
ridge  	ridge  	 JJ	I-NP
length 	length 	 NN	I-NP
.  	.  	 .	O
IFN-γ 	IFN-γ 	 NNP	B-NP
/ 	/ 	 NNP	O
CCR5  	CCR5  	 NNP	B-NP
expression  	expression  	 NN	I-NP
in  	in  	 IN	O
iNKT  	iNKT  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
and  	and  	 CC	O
CCL5  	CCL5  	 CD	B-NP
expression  	expression  	 NN	I-NP
in  	in  	 IN	O
vessels  	vessels  	 NNS	O
of  	of  	 IN	O
dermal  	dermal  	 JJ	B-NP
papillae  	papillae  	 JJ	I-NP
correlate  	correlate  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
development  	development  	 NN	O
of  	of  	 IN	O
psoriasiform  	psoriasiform  	 JJ	B-NP
hyperplasia  	hyperplasia  	 NN	I-NP
and  	and  	 CC	O
microabscess 	microabscess 	 NN	B-NP
.  	.  	 .	O
We  	We  	 PRP	O
propose  	propose  	 VBP	O
that  	that  	 IN	O
these  	these  	 DT	O
iNKT  	iNKT  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
may  	may  	 MD	O
become  	become  	 VB	O
useful  	useful  	 JJ	O
targets  	targets  	 NNS	O
for  	for  	 IN	O
development  	development  	 NN	O
of  	of  	 IN	O
novel  	novel  	 JJ	O
therapeutic  	therapeutic  	 JJ	B-NP
approaches  	approaches  	 NNS	I-NP
to  	to  	 TO	O
PV 	PV 	 NNP	B-NP
.  	.  	 .	O
